Article
Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.
Research in virology - 1 Jan 2000
Piccinino F, Felaco F M, Sagnelli E, Aprea L, Messina V, Pasquale G, Filippini P, Scolastico C
Abstract excerpt
The aims of the study were to evaluate the long-term efficacy and tolerability of different doses of interferon-alpha (IFN alpha) and different durations of treatment in chronic hepatitis C by comparing 3 or 6 mega units (MUs) three times weekly given for either 12 or 24 months, and the possibili...
Topics
- Adolescent
- Adult
- Aged
- Antiviral Agents
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Genotype
- Hepacivirus
- Hepatitis C, Chronic
- Humans
- Interferon-alpha
- Italy
- Male
- Middle Aged